{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:25:19Z","timestamp":1761531919446,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.brachy.2018.01.004","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T22:46:59Z","timestamp":1518562019000},"page":"564-570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-institutional outcomes of adjuvant brachytherapy for Stage I endometrial cancer\u2014Are outcomes consistent with randomized studies?"],"prefix":"10.1016","volume":"17","author":[{"given":"Michael J.","family":"Dohopolski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7668-6200","authenticated-orcid":false,"given":"Zachary D.","family":"Horne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Gebhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott M.","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph L.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8942-1631","authenticated-orcid":false,"given":"John T.","family":"Comerci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander B.","family":"Olawaiye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeleine","family":"Courtney-Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica L.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paniti","family":"Sukumvanich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushil","family":"Beriwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2018.01.004_bib1","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"year":"2017","series-title":"Cancer of the endometrium\u2014cancer stat facts","key":"10.1016\/j.brachy.2018.01.004_bib2"},{"year":"2017","series-title":"NCCN guidelines uterine neoplasms","key":"10.1016\/j.brachy.2018.01.004_bib3"},{"key":"10.1016\/j.brachy.2018.01.004_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0090-8258(91)90086-K","article-title":"Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study","volume":"40","author":"Morrow","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.01.004_bib5","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: Clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.brachy.2018.01.004_bib6","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2018.01.004_bib7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.brachy.2015.10.010","article-title":"Recurrences and toxicity after adjuvant vaginal brachytherapy in Stage I\u2013II endometrial cancer: A monoinstitutional experience","volume":"15","author":"Perrucci","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2018.01.004_bib8","first-page":"47","article-title":"Carcinoma of the corpus uteri","volume":"6","author":"Creasman","year":"2001","journal-title":"J Epidemiol Biostat"},{"key":"10.1016\/j.brachy.2018.01.004_bib9","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.01.004_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/gyno.1998.5155","article-title":"Adjuvant vaginal high-dose-rate afterloading alone in endometrial carcinoma: Patterns of relapse and side effects following low-dose therapy","volume":"71","author":"Weiss","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.01.004_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1999.5526","article-title":"Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy","volume":"75","author":"Chadha","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.01.004_bib12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0360-3016(99)00427-7","article-title":"High-dose-rate postoperative vaginal cuff irradiation alone for stage Ib and Ic endometrial cancer","volume":"46","author":"Anderson","year":"2000","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2018.01.004_bib13","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0360-3016(02)02792-X","article-title":"Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer","volume":"53","author":"Alektiar","year":"2002","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2018.01.004_bib14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2018.01.004_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brachy.2011.08.005","article-title":"American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy","volume":"11","author":"Small","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2018.01.004_bib16","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1200\/JCO.2015.62.5459","article-title":"Postoperative radiation therapy for endometrial cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Guideline","volume":"33","author":"Meyer","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2018.01.004_bib17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.brachy.2011.12.009","article-title":"Is there any advantage to three-dimensional planning for vaginal cuff brachytherapy?","volume":"11","author":"Kim","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2018.01.004_bib18","article-title":"A randomized phase III trial of pelvic radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel\/carboplatin chemotherapy (VCB\/C) in patients with high risk (HR), early stage endometrial cancer (EC): A Gynecologic Oncology Group tr","volume":"438","author":"Mckeekin","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.01.004_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ygyno.2013.11.005","article-title":"Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial cancer patients with high-intermediate risk factors","volume":"132","author":"Landrum","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.01.004_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brachy.2016.04.005","article-title":"American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review","volume":"16","author":"Harkenrider","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2018.01.004_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2004.09.054","article-title":"Intravaginal brachytherapy alone for intermediate-risk endometrial cancer","volume":"62","author":"Alektiar","year":"2005","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2018.01.004_bib22","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/IGC.0b013e3181a6c9df","article-title":"Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer","volume":"19","author":"Sorbe","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2018.01.004_bib23","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/IGC.0b013e3182643ba0","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma","volume":"22","author":"Sorbe","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2018.01.004_bib24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijrobp.2011.12.010","article-title":"Clinical outcomes in International Federation of Gynecology and Obstetrics stage IA endometrial cancer with myometrial invasion treated with or without postoperative vaginal brachytherapy","volume":"84","author":"Diavolitsis","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.brachy.2018.01.004_bib25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5114\/jcb.2014.45031","article-title":"Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer","volume":"6","author":"Eldredge-Hindy","year":"2014","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2018.01.004_bib26","first-page":"235","article-title":"Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma","volume":"99","author":"Horowitz","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.brachy.2018.01.004_bib27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jmig.2006.11.005","article-title":"Incidence and patient characteristics of vaginal cuff dehiscence after different modes of hysterectomies","volume":"14","author":"Hur","year":"2007","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.brachy.2018.01.004_bib28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejogrb.2005.08.009","article-title":"Transvaginal evisceration after hysterectomy: Is vaginal cuff closure associated with a reduced risk?","volume":"125","author":"De Iaco","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.brachy.2018.01.004_bib29","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer\u2014A pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472118300047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472118300047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:13:11Z","timestamp":1761531191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472118300047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1538472118300047"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2018.01.004","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-institutional outcomes of adjuvant brachytherapy for Stage I endometrial cancer\u2014Are outcomes consistent with randomized studies?","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2018.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}